Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-140732
Filing Date
2023-05-10
Accepted
2023-05-10 16:13:58
Documents
10

Document Format Files

Seq Description Document Type Size
1 DEFA14A d314698ddefa14a.htm DEFA14A 68750
2 GRAPHIC g314698dsp002.jpg GRAPHIC 964
3 GRAPHIC g314698dsp002a.jpg GRAPHIC 1080
4 GRAPHIC g314698dsp002b.jpg GRAPHIC 784
5 GRAPHIC g314698g01a03.jpg GRAPHIC 32739
6 GRAPHIC g314698g46l45.jpg GRAPHIC 4578
7 GRAPHIC g314698g53p79.jpg GRAPHIC 1944
8 GRAPHIC g314698g64a82.jpg GRAPHIC 1639
9 GRAPHIC g314698g88w65.jpg GRAPHIC 2205
10 GRAPHIC g314698g89f02.jpg GRAPHIC 1185
  Complete submission text file 0001193125-23-140732.txt   135962
Mailing Address 75 STATE ST. SUITE 100 BOSTON MA 02109
Business Address 75 STATE ST. SUITE 100 BOSTON MA 02109 (617) 213-5054
HilleVax, Inc. (Filer) CIK: 0001888012 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-41365 | Film No.: 23906525
SIC: 2836 Biological Products, (No Diagnostic Substances)